What do we do with chronic lymphocytic leukemia with 17p deletion?
about
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practice.TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program.
P2860
What do we do with chronic lymphocytic leukemia with 17p deletion?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
What do we do with chronic lymphocytic leukemia with 17p deletion?
@en
type
label
What do we do with chronic lymphocytic leukemia with 17p deletion?
@en
prefLabel
What do we do with chronic lymphocytic leukemia with 17p deletion?
@en
P2093
P2860
P1476
What do we do with chronic lymphocytic leukemia with 17p deletion?
@en
P2093
S Denzinger
S Dietrich
P2860
P2888
P356
10.1007/S11899-012-0143-0
P577
2013-03-01T00:00:00Z
P5875
P6179
1000013329